Showing 23,074 news articles about PEP

Filters Content type: Editors' picks Topic: PEP

Post-exposure prophylaxis involves taking a 28-day course of anti-HIV drugs, after possible exposure to HIV. It may be used by healthcare workers (occupational PEP) or after sex (post-exposure prophylaxis after sexual exposure, PEPSE, also known as non-occupational PEP or nPEP).

Mpox

Three Cases of Mpox Tied to Severe Illness Worry Health Experts

Editor's pick
The New York Times (requires free registration)
24 October 2025
PrEP policies & guidelines

Breakthrough HIV prevention jab given green light in South Africa

Editor's pick
Spotlight
27 October 2025
Improving HIV care

ARVs without a script: What next after major court ruling?

Editor's pick
Spotlight
27 October 2025
Clinical trials

EATG Drives Progress on Inclusion of People Living with HIV in Clinical Trials

Editor's pick
EATG
27 October 2025
Mpox

Local transmission of clade 1b mpox cases detected in EU/EEA, ECDC urges renewed vigilance

Editor's pick
European Centre for Disease Prevention and Control (ECDC)
27 October 2025
Finance & funding

Time to innovate, not panic. Here’s how South Africa should plan for HIV without donor funding

Editor's pick
Bhekisisa
27 October 2025
Activism & civil society

US: This Moment Calls for a New Brand of Heroes in HIV—And They’ve Arrived

Editor's pick
TheBody
28 October 2025
Migrants, refugees & displaced people

Are Europe’s Migrants Acquiring HIV After Arrival?

Editor's pick
Medscape (requires free registration)
28 October 2025
Health services & systems

HIV Clinicians Reveal High Rates of Service Disruptions Across US

Editor's pick
POZ
29 October 2025
HIV testing programmes & uptake

England: Thousands with undiagnosed hepatitis and HIV found in A&E testing

Editor's pick
UK Health Security Agency
30 October 2025
PrEP programmes & uptake

PrEP stigma undermines PMTCT efforts in Zimbabwe

Editor's pick
Be In The Know
30 October 2025
New & experimental HIV treatments

IDWeek 2025: Pirmitegravir demonstrates proof of concept in HIV

Editor's pick
Clinical Trials Arena
30 October 2025
Injectable & long-acting PrEP

Gilead's long-acting PrEP Yeztugo takes off while cell therapy declines continue to haunt sales

Editor's pick
FiercePharma
3 November 2025
Injectable & long-acting HIV treatment

Gilead ends phase 1 trial after settling on twice-yearly treatment partner for lenacapavir

Editor's pick
FierceBiotech
3 November 2025
Global health initiatives

With community health workers fired, who's on the frontline?

Editor's pick
Forsaken
3 November 2025
Pregnancy and vertical transmission

Missing nutrient in breast milk may explain health challenges in children of women with HIV

Editor's pick
University of California Los Angeles
3 November 2025
Drug interactions & pharmacokinetics

No Negative Impact for Individuals Taking Lenacapavir and Gender-Affirming Hormone Therapy

Editor's pick
Contagion Live
3 November 2025
Organ transplants

Evaluating Kidney Transplant Survival Outcomes in Patients With and Without HIV

Editor's pick
Infectious Disease Advisor
3 November 2025
Pregnancy and vertical transmission

Reducing premature birth risk in pregnant people with HIV

Editor's pick
CATIE
4 November 2025
Finance & funding

Withdrawal of US aid has hurt South Africa’s HIV programme

Editor's pick
Spotlight
4 November 2025
Epidemiology & behaviour

Sex for money: South African study reveals the harm that ‘blessers’ can do to young women

Editor's pick
The Conversation
7 November 2025
Government, leadership & policy

HIV knows no borders, and the Trump administration’s new strategy leave Americans vulnerable – an HIV-prevention expert explains

Editor's pick
The Conversation
7 November 2025
Elimination of hepatitis C

HCV Incidence Falls as Scotland Nears WHO Target

Editor's pick
European Medical Journal
7 November 2025
Finance & funding

When Trump’s aid cuts robbed them of HIV drugs, these people died. Now the UK is poised to slash funding further

Editor's pick
The Independent
7 November 2025